Amanote Research

Amanote Research

    RegisterSign In

The Role of Pamidronate in Pediatric Patients With Severe Osteogenesis Imperfecta

Journal of Pediatric Pharmacology and Therapeutics - United States
doi 10.5863/1551-6776-9.1.27
Full Text
Open PDF
Abstract

Available in full text

Categories
Child HealthPediatricsPerinatologyPharmacology
Date

January 1, 2004

Authors
Jennifer L. TsujiKatherine P. Smith
Publisher

Pediatric Pharmacy Advocacy Group


Related search

Modeling the Benefits of Pamidronate in Children With Osteogenesis Imperfecta

Journal of Clinical Investigation
Medicine
2002English

Splints in Severe Osteogenesis Imperfecta.

BMJ
1978English

Anthropometry of Patients With Osteogenesis Imperfecta

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1999English

Osteogenesis Imperfecta

2004English

Osteogenesis Imperfecta

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
1929English

Osteogenesis Imperfecta

English

Case Report: The Efficacy of Zolendronic Acid in Patients With Osteogenesis Imperfecta

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Osteogenesis Imperfecta

2020English

Osteogenesis Imperfecta

Proceedings of the Royal Society of Medicine
1916English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy